PMID- 28714963
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20180512
IS  - 1476-5594 (Electronic)
IS  - 0950-9232 (Linking)
VI  - 36
IP  - 38
DP  - 2017 Sep 21
TI  - FHIT loss confers cisplatin resistance in lung cancer via the
      AKT/NF-kappaB/Slug-mediated PUMA reduction.
PG  - 5439
LID - 10.1038/onc.2017.249 [doi]
AB  - This corrects the article DOI: 10.1038/onc.2014.184.
FAU - Wu, D-W
AU  - Wu DW
FAU - Lee, M-C
AU  - Lee MC
FAU - Hsu, N-Y
AU  - Hsu NY
FAU - Wu, T-C
AU  - Wu TC
FAU - Wu, J-Y
AU  - Wu JY
FAU - Wang, Y-C
AU  - Wang YC
FAU - Cheng, Y-W
AU  - Cheng YW
FAU - Chen, C-Y
AU  - Chen CY
FAU - Lee, H
AU  - Lee H
LA  - eng
PT  - Journal Article
PT  - Published Erratum
DEP - 20170717
PL  - England
TA  - Oncogene
JT  - Oncogene
JID - 8711562
EFR - Oncogene. 2015 May 7;34(19):2505-15. PMID: 24998847
EDAT- 2017/07/18 06:00
MHDA- 2017/07/18 06:01
CRDT- 2017/07/18 06:00
PHST- 2017/07/18 06:00 [pubmed]
PHST- 2017/07/18 06:01 [medline]
PHST- 2017/07/18 06:00 [entrez]
AID - onc2017249 [pii]
AID - 10.1038/onc.2017.249 [doi]
PST - ppublish
SO  - Oncogene. 2017 Sep 21;36(38):5439. doi: 10.1038/onc.2017.249. Epub 2017 Jul 17.